Clinical Report: Impact of Metagenomic NGS on CNS Infection Diagnostics

Overview

Metagenomic next-generation sequencing (mNGS) shows promise in improving diagnosis of central nervous system (CNS) infections by reducing diagnostic delays, lumbar punctures, and additional microbiological tests. Modeling based on a cohort of patients with infectious and autoimmune encephalitis suggests mNGS could significantly streamline clinical workflows and shorten time to diagnosis.

Background

Diagnosing meningitis and encephalitis is challenging due to nonspecific symptoms and limitations of traditional microbiological methods, which often delay diagnosis and treatment. Conventional testing targets a narrow range of pathogens and can have variable sensitivity and accessibility. Metagenomic next-generation sequencing (mNGS) offers unbiased detection of pathogens from cerebrospinal fluid, potentially increasing diagnostic yield and reducing time to diagnosis. However, its clinical utility and impact on resource allocation in real-world settings remain to be fully defined.

Data Highlights

Key Findings

• mNGS testing could reduce the number of microbiological tests by up to 88 in DNA viral CNS infections and 30 in bacterial infections.
• Time to diagnosis could be shortened by approximately 144–145 days for bacterial and DNA viral infections, respectively.
• Use of mNGS may reduce lumbar punctures by 2 in DNA viral infections and 12 in bacterial infections, improving patient comfort and safety.
• In autoimmune encephalitis cases, mNGS could avoid 126 microbiological tests, 2 lumbar punctures, and reduce diagnosis time by 297 days.
• Positive predictive values for mNGS were high across fungal (92.8%), RNA viral (89.5%), and parasitic (84.6%) infections despite their lower prevalence.
• mNGS platforms like Delve Detect can detect both RNA and DNA pathogens with turnaround times around 48 hours, enhancing diagnostic yield by over 20% compared to traditional methods.

Clinical Implications

Incorporating mNGS into diagnostic pathways for meningitis and encephalitis could substantially reduce diagnostic delays and invasive procedures such as lumbar punctures. This approach may enable more targeted therapies earlier in the clinical course, reduce unnecessary testing, and improve resource allocation. Clinicians should consider mNGS as a complementary tool, especially in cases where traditional diagnostics are inconclusive or delayed.

Conclusion

Metagenomic next-generation sequencing has the potential to transform the diagnostic approach to CNS infections and autoimmune encephalitis by enabling faster, more comprehensive pathogen detection. Its integration into clinical workflows could streamline diagnostics, reduce patient burden, and optimize healthcare resources.

References

1. Wilson et al. 2019 -- Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Diseases
2. Miller et al. 2021 -- Clinical Utility of mNGS in CNS Infections
3. Columbia University Irving Medical Center Study 2010-2017 -- CNS Infection Diagnostic Cohort